跳至主要内容
临床试验/NCT01843985
NCT01843985Unknown不适用

Observational Study of Survival Times of Stage IV Cancer Patients

Cure Cancer Worldwide Corporation1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2013年6月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
120
试验地点
1
主要终点
survival

研究概览

简要总结

Patients diagnosed with Stage IV cancer (solid tumors only) are evaluated to determine whether they are candidates for traditional chemotherapy. If eligible, patients are offered traditional chemotherapy, low-dose chemotherapy, or palliative care. If ineligible, patients are offered low-dose chemotherapy or palliative care. Patients will be monitored for 5 years and survival data recorded.

研究设计

研究类型
Observational

入排标准

性别
All
接受健康志愿者

入选标准

  • Presenting with Stage IV cancer (solid tumors only)

排除标准

  • Patient declines inclusion

结局指标

主要结局

survival

时间窗: months 1, 2, 3, 4, 6, 9, 12, 18, 24, 36, 48, 60

次要结局

未报告次要终点

研究者

发起方
Cure Cancer Worldwide Corporation
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Observational Study of Survival Outcomes of Stage IV... | 临床试验